Elliptic Laboratories AS (OL:ELABS) — Stock Price
Elliptic Laboratories AS (OL:ELABS) is currently trading at Nkr2.39 NOK, down 1.65% today. Over the past 52 weeks, shares have ranged between Nkr2.39 and Nkr12.40. This page tracks Elliptic Laboratories AS's live share price on the OL exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Elliptic Laboratories AS (ELABS) total market value.
Elliptic Laboratories AS (ELABS) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Elliptic Laboratories AS's daily closing share price and trading volume on the OL exchange over the past year, giving a clear view of recent price momentum and liquidity.
Elliptic Laboratories AS Income Statement — Revenue, Profit & Earnings by Year
Elliptic Laboratories AS's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | Nkr101.31 Million | Nkr131.91 Million | Nkr68.32 Million | Nkr52.06 Million | Nkr54.60 Million |
| Cost of Revenue | Nkr88.64 Million | Nkr87.86 Million | Nkr80.55 Million | Nkr62.80 Million | Nkr50.81 Million |
| Gross Profit | Nkr12.66 Million | Nkr44.05 Million | Nkr-12.23 Million | Nkr-10.74 Million | Nkr3.79 Million |
| Research & Development | — | Nkr26.65 Million | Nkr21.29 Million | Nkr8.14 Million | Nkr5.70 Million |
| SG&A | Nkr88.64 Million | Nkr5.69 Million | Nkr8.08 Million | Nkr5.97 Million | Nkr5.59 Million |
| Total Operating Expenses | Nkr146.75 Million | Nkr39.34 Million | Nkr37.51 Million | Nkr31.39 Million | Nkr14.93 Million |
| Operating Income | Nkr-45.44 Million | Nkr4.71 Million | Nkr-49.74 Million | Nkr-42.13 Million | Nkr-11.14 Million |
| EBITDA | — | Nkr25.69 Million | Nkr-39.79 Million | Nkr-26.75 Million | Nkr-9.29 Million |
| EBIT | — | Nkr19.43 Million | Nkr-56.02 Million | Nkr-38.07 Million | Nkr-11.90 Million |
| Interest Expense | Nkr11.60 Million | Nkr2.38 Million | Nkr2.43 Million | Nkr2.70 Million | Nkr1.45 Million |
| Income Before Tax | Nkr-58.23 Million | Nkr17.05 Million | Nkr-46.86 Million | Nkr-39.30 Million | Nkr-13.09 Million |
| Income Tax Expense | — | Nkr8.09 Million | Nkr-8.86 Million | Nkr-6.30 Million | Nkr-1.88 Million |
| Net Income | Nkr-138.16 Million | Nkr8.96 Million | Nkr-38.00 Million | Nkr-33.00 Million | Nkr-11.21 Million |
Elliptic Laboratories AS Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Elliptic Laboratories AS's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | Nkr221.66 Million | Nkr361.03 Million | Nkr348.20 Million | Nkr349.32 Million | Nkr371.36 Million |
| Total Current Assets | Nkr132.18 Million | Nkr195.45 Million | Nkr185.64 Million | Nkr225.62 Million | Nkr264.95 Million |
| Cash & Equivalents | Nkr43.06 Million | Nkr74.20 Million | Nkr112.77 Million | Nkr176.44 Million | Nkr216.83 Million |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | Nkr81.00 Million | Nkr117.52 Million | Nkr60.61 Million | Nkr40.49 Million | Nkr29.02 Million |
| Inventory | — | — | — | — | — |
| Property, Plant & Equipment | Nkr12.41 Million | Nkr16.66 Million | Nkr19.91 Million | Nkr2.26 Million | Nkr2.79 Million |
| Goodwill | — | — | — | — | — |
| Total Liabilities | Nkr31.87 Million | Nkr35.69 Million | Nkr42.80 Million | Nkr23.70 Million | Nkr28.59 Million |
| Total Current Liabilities | Nkr23.56 Million | Nkr24.96 Million | Nkr24.93 Million | Nkr17.18 Million | Nkr18.06 Million |
| Long-term Debt | Nkr0.00 | Nkr0.00 | Nkr2.00 Million | Nkr6.00 Million | Nkr10.00 Million |
| Net Debt | — | Nkr-57.04 Million | Nkr-89.72 Million | Nkr-165.51 Million | Nkr-201.01 Million |
| Total Stockholder Equity | Nkr189.79 Million | Nkr325.34 Million | Nkr305.40 Million | Nkr325.62 Million | Nkr342.77 Million |
| Retained Earnings | — | — | — | — | — |
Elliptic Laboratories AS Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Elliptic Laboratories AS generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | Nkr5.99 Million | Nkr-10.61 Million | Nkr-45.51 Million | Nkr-12.76 Million | Nkr-10.82 Million |
| Capital Expenditures | Nkr29.08 Million | Nkr30.50 Million | Nkr25.61 Million | Nkr23.33 Million | Nkr17.61 Million |
| Free Cash Flow | Nkr-41.11 Million | Nkr-41.11 Million | Nkr-71.12 Million | Nkr-36.09 Million | Nkr-28.43 Million |
| Investing Cash Flow | Nkr-26.86 Million | Nkr-24.55 Million | Nkr-20.97 Million | Nkr-23.33 Million | Nkr-17.61 Million |
| Financing Cash Flow | Nkr-10.31 Million | Nkr-7.13 Million | Nkr2.21 Million | Nkr-4.26 Million | Nkr146.80 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | Nkr5.47 Million | Nkr5.47 Million | Nkr9.84 Million | Nkr12.46 Million | Nkr10.35 Million |
| Depreciation | Nkr25.32 Million | Nkr21.86 Million | Nkr4.64 Million | Nkr11.32 Million | Nkr8.31 Million |
| Change in Cash | Nkr-33.33 Million | Nkr-39.19 Million | Nkr-62.64 Million | Nkr-39.93 Million | Nkr118.43 Million |
Elliptic Laboratories AS Earnings History — EPS Actual vs. Analyst Estimates
Track Elliptic Laboratories AS's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Aug 27, 2026 | — | — | — |
| May 21, 2026 | — | — | — |
| Feb 26, 2026 | -0.90 | 0.16 | -662.50% |
| Nov 20, 2025 | 0.03 | 0.20 | -85.00% |
| Aug 28, 2025 | -0.08 | 0.02 | -500.00% |
| May 22, 2025 | -0.12 | -0.01 | -1100.00% |
| Feb 27, 2025 | 0.10 | — | — |
| Nov 29, 2024 | -0.04 | — | — |